FundedIQ
Biotechnology

Callio Therapeutics: Funding, Investors & Team (Oct 2026)

calliotx.com LinkedIn Seattle, United States 1-10 employees
Total raised
$187M
Rounds
1
Latest
Series A
Mar 2025

Callio Therapeutics has raised $187M across 1 funding round on record, the most recent a Series A of $187M announced in Mar 2025.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Callio Therapeutics Company Profile and Key Stats

Total funding raised
$187M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$187M in Mar 2025
Employees
1-10
reported band
Headquarters
Seattle, United States

Latest funding round on record: Mar 2025.

Callio Therapeutics Funding Rounds

Date
Round
Amount
Series A
$187M

Callio Therapeutics Founders and Leadership Team

Name
Role
Contact
Jerome Boyd Kirkup
Founder
—

No contact details are on record for this team yet.

Callio Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,148
$7.5M
8,523
$15M

Callio Therapeutics' latest round of $187M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Callio Therapeutics in Biotechnology and Seattle

Companies Similar to Callio Therapeutics

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

Callio Therapeutics Funding FAQs

How much funding has Callio Therapeutics raised?

Callio Therapeutics has raised $187M across 1 round on record. The most recent is a Series A of $187M announced in Mar 2025.

When did Callio Therapeutics last raise funding?

Callio Therapeutics' most recent funding round on record is a Series A of $187M, announced in Mar 2025.

Who founded Callio Therapeutics?

FundedIQ lists Jerome Boyd Kirkup (Founder) at Callio Therapeutics.

Where is Callio Therapeutics headquartered?

Callio Therapeutics is based in Seattle, Washington, United States.

How many employees does Callio Therapeutics have?

Callio Therapeutics is in the 1-10 employee band.

How does Callio Therapeutics' funding compare to other Biotechnology startups?

Callio Therapeutics' latest round of $187M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Callio Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Callio Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.